rts logo

New Big Money Means Lexicon Pharmaceuticals Inc (LXRX) Investors Could Reap Benefit

Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is 6.54% higher on its value in year-to-date trading and has touched a low of $0.92 and a high of $3.73 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LXRX stock was last observed hovering at around $1.60 in the last trading session, with the day’s gains setting it 0.03%.

Currently trading at $1.63, the stock is -6.52% and -6.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.66 million and changing 1.87% at the moment leaves the stock -3.14% off its SMA200. LXRX registered -30.04% loss for a year compared to 6-month gain of 6.54%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -6.86% loss in the last 1 month and extending the period to 3 months gives it a -21.26%, and is 1.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.48% over the week and 6.80% over the month.

Lexicon Pharmaceuticals Inc (LXRX) has around 285 employees, a market worth around $589.23M and $2.31M in sales. Profit margin for the company is -8311.12%. Distance from 52-week low is 77.17% and -56.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-48.77%).

The EPS is expected to grow by 11.96% this year

The shares outstanding are 361.49M, and float is at 351.32M with Short Float at 6.14%.

Lexicon Pharmaceuticals Inc (LXRX) Insider Activity

The most recent transaction is an insider purchase by COATS LONNEL, the company’s Chief Executive Officer. SEC filings show that COATS LONNEL bought 90,000 shares of the company’s common stock on Nov 16 ’23 at a price of $1.05 per share for a total of $94797.0. Following the purchase, the insider now owns 0.91 million shares.

Lexicon Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 10 ’23 that COATS LONNEL (Chief Executive Officer) bought a total of 10,000 shares of the company’s common stock. The trade occurred on Nov 10 ’23 and was made at $1.01 per share for $10100.0. Following the transaction, the insider now directly holds 0.82 million shares of the LXRX stock.

Still, SEC filings show that on Oct 12 ’23, DEBBANE RAYMOND (Director) acquired 148,820 shares at an average price of $1.03 for $0.15 million. The insider now directly holds 1,340,847 shares of Lexicon Pharmaceuticals Inc (LXRX).

Related Posts